Skip to main content
Equibles

Legal & General Group Plc

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 764068 London, X0
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,308,915
+$257,672 QoQ
Shares Held
356,653
+4.2% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 344 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. RXRX ranks #100 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in RXRX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,308,915 356,653
2026-03-31 $1,051,243 342,425
2025-12-31 $1,491,621 364,700
2025-09-30 $1,725,605 353,608
2025-06-30 $1,592,811 314,785
2025-03-31 $1,311,823 247,982
2024-12-31 $1,713,158 253,426
2024-09-30 $1,222,266 185,473
2024-06-30 $1,358,572 181,143
2024-03-31 $1,512,837 151,739
2023-12-31 $1,278,062 129,621
2023-09-30 $903,081 118,050
2023-06-30 $833,539 111,585
2023-03-31 $670,667 100,550
2022-12-31 $724,508 93,970
2022-09-30 $952,354 89,507
2022-06-30 $914,423 112,337
2022-03-31 $463,165 64,688
2021-12-31 $355,497 20,753
2021-09-30 $62,265 2,706
2021-06-30 $74,861 2,051